Insulet Corporation (PODD) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Insulet Corporation (PODD) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

PODD

Market Closed

Insulet Corporation

NASDAQHealthcare Medical - Devices

5.40K employees

CEO: Ashley A. McEvoy

Founded: 2007

$145.76

+$0.00(+NaN%)

Market Cap

10.10B

Beta

1.13

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

71.6%

34.2%

CAGR: 26.7%

Profit after direct costs

Operating Margin

17.5%

53.4%

CAGR: 39.3%

Core business profitability

Net Margin

9.1%

-40.9%

CAGR: 95.8%

Bottom line profitability

Revenue Growth

30.7%

YoY

CAGR: 25.3%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how PODD allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

71.6%

$1.94B

Operating Margin

17.5%

$473.80M

Net Margin

9.1%

$247.10M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	1.10B	1.31B	1.70B	2.07B	2.71B	30.7%
Cost of Revenue	(346.70M)	(499.70M)	(537.20M)	(625.90M)	(768.20M)	22.7%
Gross Profit	752.10M	805.60M	1.16B	1.45B	1.94B	34.2%
Operating Expenses
Research & Development	(160.10M)	(180.20M)	(205.00M)	(219.60M)	(301.10M)	37.1%
Selling, General & Administrative	(466.00M)	(587.80M)	(734.90M)	(917.20M)	(1.17B)	27.0%
Depreciation & Amortization	(57.40M)	(63.20M)	(72.80M)	(80.80M)	(113.10M)	40.0%
Operating Income (EBIT)	126.00M	37.60M	220.00M	308.90M	473.80M	53.4%
Non-Operating Items
Interest Income	500.00K	9.30M	28.60M	39.50M	34.70M	-12.2%
Interest Expense	(61.70M)	(36.00M)	(36.20M)	(42.70M)	(79.70M)	86.7%
Other Income/Expenses (Net)	-105.50M	-27.80M	-5.40M	-8.70M	-134.30M	1443.7%
Income Before Tax	20.50M	9.80M	214.60M	300.20M	339.50M	13.1%
Income Tax Expense	(3.70M)	(5.20M)	(8.30M)	(118.10M)	(92.40M)	-178.2%
Net Income	16.80M	4.60M	206.30M	418.30M	247.10M	-40.9%
Per Share Metrics
Earnings Per Share (Basic)	$0	$0	$3	$6	$4	-41.2%
Weighted Avg Shares Outstanding	67.70M	69.38M	69.75M	70.08M	70.35M	0.4%
Weighted Avg Shares Outstanding (Diluted)	68.58M	69.91M	73.63M	73.89M	71.89M	-2.7%
EBITDA	139.60M	109.00M	323.60M	423.70M	532.30M	25.6%

Explore PODD

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PODD in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →